Mar 14, 2023 / 05:20PM GMT
Michael David Wiederhorn - Oppenheimer & Co. Inc., Research Division - MD & Senior Analyst
Good afternoon. Welcome to Oppenheimer's 33rd Annual Healthcare Conference. I'm Mike Wiederhorn, the healthcare services analyst. It's my pleasure to have Chemed Corporation today. We have President and CEO, Kevin McNamara; and Chief Financial Officer, David Williams. This is going to be fireside. Welcome, guys. Thanks for joining us today.
David P. Williams - Chemed Corporation - Executive VP & CFO
Thanks, Mike.
Questions and Answers:
Michael David Wiederhorn - Oppenheimer & Co. Inc., Research Division - MD & Senior AnalystThank you. I'll start off with a general question. Can you just kind of give us your thoughts around now that you're a few months into 2023 under your belt, how should we view trends in the business? And do you think we can use this year as a normalized base to grow off of?
Kevin J. McNamara - Chemed Corporation - CEO, President & Director